Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretransected peripheral nerve

Journal of Neurosurgery

Volumn 84, Issue 4, 1996, Pages 685-689

  Date, Isao ^a   Imaoka, Takashi ^a   Miyoshi, Yasuvuki ^a   Ono, Takeshi ^a   Asari, Shoji ^a   Ohmoto, Takashi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Autopsy; Chromaffin cell; Cograft; Nerve transplantation; Parkinson's disease; Peripheral nerve

Indexed keywords

CARBIDOPA PLUS LEVODOPA; TYROSINE 3 MONOOXYGENASE;

ADRENAL MEDULLA; ADULT; AKINESIA; ARTICLE; CASE REPORT; CAUDATE NUCLEUS; CELL SURVIVAL; CHROMAFFIN CELL; DOPAMINERGIC NERVE CELL; FEMALE; HISTOPATHOLOGY; HUMAN; NERVE TRANSECTION; PARKINSON DISEASE; PERIPHERAL NERVE; PRIORITY JOURNAL; SURAL NERVE; TISSUE GRAFT;

ADRENAL MEDULLA; BRAIN TISSUE TRANSPLANTATION; CELL SURVIVAL; DOPAMINE; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NERVE FIBERS; PARKINSON DISEASE; PERIPHERAL NERVES;

EID: 0029864580     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.84.4.0685     Document Type: Article

References (33)

1. Bakay RAE: Neurotransplantation: a clinical update. Acta Neurochir Suppl 58:8-16, 1993
2. Bohn MC, Cupit L, Marciano F, et al: Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 237: 913-916, 1987
3. CAPIT Committee (Langston WJ, Widner H, Goetz CG. et al): Core assessment program for intracerebral transplantations (CAPIT). Mov Disorders 7:2-13, 1992
4. Clayton GH, Mahalik TJ, Finger TE: GAP-43 and 5B4-CAM immunoreactivity during the development of transplanted fetal mesencephalic neurons. Exp Neurol 114:1-10, 1991
5. Cunningham LA, Short MP, Breakefield XO, et al: Nerve growth factor released by transgenic astrocytes enhances the function of adrenal chromaffin cell grafts in a rat model of Parkinson's disease. Brain Res 658:219-231, 1994
6. Date I, Asari S, Ohmoto T: Two-year follow-up study of a patient with Parkinson's disease and severe motor fluctuations treated by co-grafts of adrenal medulla and peripheral nerve into bilateral caudate nuclei: case report. Neurosurgery 37: 515-519, 1995
7. Date I, Felten SY, Felten DL: Cografts of adrenal medulla with peripheral nerve enhance the survivability of transplanted adrenal chromaffin cells and recovery of the host nigrostriatal dopaminergic system in MPTP-treated young adult mice. Brain Res 537:33-39, 1990
8. Date I, Felten SY, Felten DL: The nigrostriatal dopaminergic system in MPTP-treated mice shows more prominent recovery by syngeneic adrenal medullary graft than by allogeneic or xenogeneic graft. Brain Res 545:191-198, 1991
9. Date I, Felten SY, Olschowka JA, et al: Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging mice. Exp Neurol 107:197-207, 1990
10. Date I, Furukawa S, Ohmoto T: Increased nerve growth factor level in the distal stump of transected sciatic nerve in relation to aging and its application for neural srafting. Exp Neurol 130: 168-171, 1994
11. Date I, Miyoshi Y, Imaoka T, et al: Efficacy of pretransection of peripheral nerve for promoting the survival of cografted chromaffin cells and recovery of host dopaminergic fibers in animal models of Parkinson's disease. Neurosci Res 20: 213-221, 1994
12. Date I, Yoshimoto Y, Gohda Y, et al: Long-term effects of cografts of pretransected peripheral nerve with adrenal medulla m animal models of Parkinson's disease. Neurosurgery 33: 685-690, 1993
13. Date I, Yoshimoto Y, Imaoka T, et al: Effect of host age upon the degree of nigrostriatal dopaminergic system recovery following cografts of adrenal medulla and pretransected peripheral nerve. Brain Res 637:50-56, 1994
14. Date I, Yoshimoto Y, Miyoshi Y, et al: The influence of donor age on cografting of adrenal medulla with pretransected peripheral nerve. Brain Res 624:233-238, 1993
15. Fiandaca MS, Kordower JH, Hansen JT, et al: Adrenal medullary autografts into the basal ganglia of cebus monkeys: injury-induced regeneration. Exp Neurol 102:76-91, 1988
16. Forno LS, Langston JW: Unfavorable outcome of adrenal medullary transplant for Parkinson's disease, Acta Neuropathol 81:691-694, 1991
17. Hirsch EC, Duyckaerts C, Javoy-Agid F, et al: Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease? Ann Neurol 27:676-682, 1990
18. Hoehn MM, Yahr MD: Parkinsonism: onset, progression, and mortality. Neurology 17:427-442, 1967
19. Hurtig H, Joyce J, Sladek JR Jr, et al: Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease. Ann Neurol 25:607-614, 1989
20. Jankovic J, Grossman R, Goodman C, et al: Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease. Neurology 39:1227-1234, 1989
21. Kordower JH, Cochran E, Penn RD, et al: Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease. Ann Neurol 29:405-412, 1991
22. Kordower JH, Fiandaca MS, Notter MFD, et al: NGF-like trophic support from peripheral nerve for grafted rhesus adrenal chromaffin cells. J Neurosurg 73:418-428, 1990
23. Kordower JH, Freeman TB, Snow BJ, et al: Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:1118-1124, 1995
24. Lindvall O: Transplantation into the human brain: present status and future possibilities. J Neurol Neurosurg Psychiatry Suppl:39-54, 1989
25. López-Lozano JJ, Bravo G, Abascal J, et al: Co-transplantation of peripheral nerve and adrenal medulla in Parkinson's disease. Lancet 339:430, 1992 (Letter)
26. Olson L, Backlund EO, Ebendal T, et al: Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial. Arch Neurol 48:373-381, 1991
27. Peterson DI, Price ML, Small CS: Autopsy findings in a patient who had an adrenal-to-brain transplant for Parkinson's disease. Neurology 39:235-238, 1989
28. Solà C, Mengod G, Low WC, et al: Regional distribution of amyloid β-protein precursor, growth-associated phosphoprotein-43 and microtubule-associated protein 2 messenger RNAs in the nigrostriatal system of normal and Weaver mutant mice and effects of ventral mesencephalic grafts. Eur J Neurosci 5: 1442-1454, 1993
29. Springer JE: Nerve growth factor receptors in the central nervous system. Exp Neurol 102:354-365, 1988
30. Strömberg I, Herrera-Marschitz M, Ungerstedt U, et al: Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior. Exp Brain Res 60:335-349, 1985
31. Unsicker K: The trophic cocktail made by adrenal chromaffin cells. Exp Neurol 123:167-173, 1993
32. Unsicker K, Krisch B, Otten U, et al: Nerve growth factor-induced fiber outgrowth from isolated rat adrenal chromaffin cells: impairment by glucocorticoids. Proc Natl Acad Sci USA 75:3498-3502, 1978
33. Waters C, Itabashi HH, Apuzzo LJ, et al: Adrenal to caudate transplantation - postmortem study. Mov Disord 5:248-250, 1990